Transgene Biotek (BOM:526139) Short-Term Debt : ₹0.00 Mil (As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Transgene Biotek Short-Term Debt?

Transgene Biotek's Short-Term Debt for the quarter that ended in Dec. 2024 was ₹0.00 Mil.

Transgene Biotek's quarterly Short-Term Debt increased from Jun. 2024 (₹0.00 Mil) to Sep. 2024 (₹89.95 Mil) but then declined from Sep. 2024 (₹89.95 Mil) to Dec. 2024 (₹0.00 Mil).

Transgene Biotek's annual Short-Term Debt increased from Mar. 2022 (₹72.39 Mil) to Mar. 2023 (₹81.62 Mil) and increased from Mar. 2023 (₹81.62 Mil) to Mar. 2024 (₹89.22 Mil).

Transgene Biotek Short-Term Debt Historical Data

The historical data trend for Transgene Biotek's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transgene Biotek Short-Term Debt Chart

Transgene Biotek Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Short-Term Debt

Get a 7-Day Free Trial

60.51

67.88

72.39

81.62

89.22

Transgene Biotek Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Short-Term Debt	Get a 7-Day Free Trial															-	89.22	-	89.95	-

Transgene Biotek Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Transgene Biotek Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Transgene Biotek's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Transgene Biotek Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgene Biotek Ltd (BOM:526139) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Anrich Industrial Area, Plot No. 69 and 70, IDA Bollaram, Sangareddy District, Medak, TG, IND, 502325

Website

https://www.transgenebiotek.com

Transgene Biotek Ltd is an India-based research and development company. It is engaged in the research and development of molecules and technologies for the production of active pharmaceutical ingredients and other pharmaceutical products. The company is operating only in one segment of Bulk Drugs. Its product portfolio includes TrabiDHA, Tracolimus, and Orlistat. It generates revenue from the sale of goods and services.

Transgene Biotek Headlines

No Headlines